Literature DB >> 11592077

Activation through CD40 ligation induces functional Fas ligand expression by Langerhans cells.

A Shibaki1, S I Katz.   

Abstract

Langerhans cells (LC) are professional antigen-presenting cells of dendritic cell (DC) lineage and are critical for the induction of primary immune responses in skin. Following antigenic stimulation, LC migrate to regional lymph nodes and induce antigen-specific activation of T cells. After primary expansion, the majority of T cells undergo Fas/Fas ligand (FasL)-mediated apoptotic cell death, thereby suppressing their excessive expansion. Although recent investigations have indicated an immunoregulatory function for DC, whether LC could be involved in Fas/FasL-mediated suppression of activated T cells is still unclear. In this study, we found that LC express FasL after activation triggered through CD40 molecules on their surface, but not by stimulation with LPS or IFN-gamma. The functional significance of FasL expression by LC was demonstrated using two different assays for apoptosis induced in Jurkat cells. The apoptosis in Jurkat cells was completely blocked by anti-FasL blocking antibody, suggesting a Fas/FasL-mediated mechanism. These results indicate a new feedback mechanism to down-regulate T cell activation by LC through the interaction of the TNF receptor/ligand superfamily, CD40/CD40L and Fas/FasL.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11592077     DOI: 10.1002/1521-4141(2001010)31:10<3006::aid-immu3006>3.0.co;2-l

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

1.  Th-1 lymphocytes induce dendritic cell tumor killing activity by an IFN-γ-dependent mechanism.

Authors:  Collin J LaCasse; Nona Janikashvili; Claire B Larmonier; Darya Alizadeh; Neale Hanke; Jessica Kartchner; Elaine Situ; Sara Centuori; Michael Har-Noy; Bernard Bonnotte; Emmanuel Katsanis; Nicolas Larmonier
Journal:  J Immunol       Date:  2011-11-09       Impact factor: 5.422

Review 2.  In vivo function of Langerhans cells and dermal dendritic cells.

Authors:  Daniel H Kaplan
Journal:  Trends Immunol       Date:  2010-10-28       Impact factor: 16.687

3.  Anticancer Mechanisms in Two Murine Bone Marrow-Derived Dendritic Cell Subsets Activated with TLR4 Agonists.

Authors:  Alexander Bagaev; Aleksey Pichugin; Edward L Nelson; Michael G Agadjanyan; Anahit Ghochikyan; Ravshan I Ataullakhanov
Journal:  J Immunol       Date:  2018-03-02       Impact factor: 5.422

4.  Use of interleukin 7 receptor-alpha knockout donor cells demonstrates the lymphoid independence of dendritic cells.

Authors:  Satoshi Takeuchi; Stephen I Katz
Journal:  Blood       Date:  2005-09-15       Impact factor: 22.113

5.  Decrease of CD154 intensity on peripheral CD4+ T cells in autoimmune thyroid disease.

Authors:  M Watanabe; N Yamamoto; F Matsuzuka; A Miyauchi; Y Iwatani
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

6.  Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and langerhans cell-derived IL-10.

Authors:  Botond Z Igyarto; Matthew C Jenison; Jan C Dudda; Axel Roers; Werner Müller; Pandelakis A Koni; Daniel J Campbell; Mark J Shlomchik; Daniel H Kaplan
Journal:  J Immunol       Date:  2009-10-15       Impact factor: 5.422

Review 7.  Dendritic cell tumor killing activity and its potential applications in cancer immunotherapy.

Authors:  Neale Hanke; Darya Alizadeh; Emmanuel Katsanis; Nicolas Larmonier
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

8.  Up-regulation of Fas (CD95) expression in tumour cells in vivo.

Authors:  Naama Peshes-Yaloz; Dalia Rosen; Paul M Sondel; Peter H Krammer; Gideon Berke
Journal:  Immunology       Date:  2007-04       Impact factor: 7.397

9.  Human B Cell-Derived Lymphoblastoid Cell Lines Constitutively Produce Fas Ligand and Secrete MHCII(+)FasL(+) Killer Exosomes.

Authors:  Matthew W Klinker; Vincent Lizzio; Tamra J Reed; David A Fox; Steven K Lundy
Journal:  Front Immunol       Date:  2014-04-02       Impact factor: 7.561

10.  Interleukin-5 supports the expansion of fas ligand-expressing killer B cells that induce antigen-specific apoptosis of CD4(+) T cells and secrete interleukin-10.

Authors:  Matthew W Klinker; Tamra J Reed; David A Fox; Steven K Lundy
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.